Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib

Peer Review reports

Original Submission
29 Dec 2022	Submitted	Original manuscript
15 Feb 2023	Author responded	Author comments - Kazuhiro Tanaka
Resubmission - Version 2
15 Feb 2023	Submitted	Manuscript version 2
20 Feb 2023	Author responded	Author comments - Kazuhiro Tanaka
Resubmission - Version 3
20 Feb 2023	Submitted	Manuscript version 3
Publishing
28 Feb 2023	Editorially accepted
8 Mar 2023	Article published	10.1186/s12885-023-10693-w

Back to article page